PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-188.64%
Both yoy net incomes decline, with EQT at -255.18%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
No Data
No Data available this quarter, please select a different quarter.
11.84%
Some yoy growth while EQT is negative at -273.87%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-15.09%
Both cut yoy SBC, with EQT at -5.81%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-53.33%
Both reduce yoy usage, with EQT at -1369.81%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-342.86%
Both yoy AR lines negative, with EQT at -772.05%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-53.33%
Both reduce yoy usage, with EQT at -263.92%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-24.19%
Negative yoy while EQT is 539.57%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
6.99%
Operating cash flow growth at 75-90% of EQT's 8.14%. Bill Ackman would recommend further refinements to match competitor’s CFO gains.
-72.20%
Both yoy lines negative, with EQT at -276.07%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-99.23%
Negative yoy acquisition while EQT stands at 189.10%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
1080.00%
Purchases growth of 1080.00% while EQT is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
72.20%
Liquidation growth of 72.20% while EQT is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-47.32%
Both yoy lines negative, with EQT at -699.47%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-129.52%
Both yoy lines negative, with EQT at -59.60%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
98.87%
We repay more while EQT is negative at -414.07%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-84.91%
Negative yoy issuance while EQT is 100.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.